BIO-Europe Spring® 2016: Accellta CEO says israeli stem cell specialist seeks global partners

May 17, 2016
Accellta CEO Itzchak Angel speaks to Informa senior editor and writer Sten Stovall during the BIO-Europe Spring® partnering conference in Stockholm, Sweden about the Israeli stem cell specialist's stem cell culturing process and future expansion plans including a planned USD 15 million capital-raising exercise and ongoing search for future corporate partners. The potential applications of Accellta's technologies include the development of cell-based medical therapies, research tools and methods, drug screening and development and tissue engineering.
Previous Video
BIO-Europe Spring® 2016: BeyondSpring Pharmaceuticals outlines Plinabulin plans
BIO-Europe Spring® 2016: BeyondSpring Pharmaceuticals outlines Plinabulin plans

Next Video
BIO-Europe Spring® 2016: AngioDesign tailoring next-generation ACE inhibitors
BIO-Europe Spring® 2016: AngioDesign tailoring next-generation ACE inhibitors

Mario Ehlers, the chairman and founder of Angio-Design (UK) speaks to Informa senior editor and writer Sten...